Biosource International Inc Sample Contracts

AutoNDA by SimpleDocs
ARTICLE I.
Securities Purchase Agreement • October 26th, 2000 • Biosource International Inc • In vitro & in vivo diagnostic substances • California
EXHIBIT 1.1 BIOSOURCE INTERNATIONAL, INC. 4,000,000 Shares/1/ Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • April 13th, 2000 • Biosource International Inc • In vitro & in vivo diagnostic substances • California
WAIVER TO INVESTOR RIGHTS AGREEMENT
Investor Rights Agreement • October 26th, 2000 • Biosource International Inc • In vitro & in vivo diagnostic substances
RECITALS:
Separation and Release Agreement • March 29th, 2004 • Biosource International Inc • In vitro & in vivo diagnostic substances • California
RECITALS
Separation and Consulting Agreement • March 27th, 2001 • Biosource International Inc • In vitro & in vivo diagnostic substances • California
AGREEMENT AND PLAN OF MERGER Dated as of July 25, 2005 among INVITROGEN CORPORATION, ERROL ACQUISITION CORPORATION and BIOSOURCE INTERNATIONAL, INC.
Agreement and Plan of Merger • July 26th, 2005 • Biosource International Inc • In vitro & in vivo diagnostic substances • Delaware

This AGREEMENT AND PLAN OF MERGER, dated as of July 25, 2005 (this “Agreement”), is among INVITROGEN CORPORATION, a Delaware corporation (“Parent”), ERROL ACQUISITION CORPORATION, a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and BIOSOURCE INTERNATIONAL, INC., a Delaware corporation (the “Company”). Certain terms used in this Agreement are used as defined in Section 8.11.

AMENDMENT NO. 1 TO WARRANT TO PURCHASE COMMON STOCK OF BIOSOURCE INTERNATIONAL, INC.
Biosource International Inc • June 8th, 2004 • In vitro & in vivo diagnostic substances
BIOSOURCE INTERNATIONAL, INC. EXECUTIVE SEVERANCE AGREEMENT
Executive Severance Agreement • June 13th, 2005 • Biosource International Inc • In vitro & in vivo diagnostic substances • California

THIS AGREEMENT between Alan I. Edrick (the “Executive”) and BioSource International, Inc. (the “Company”) has been entered into as of June 7, 2005. This Agreement requires the Company to pay Severance Benefits upon termination of the Executive’s employment with the Company in connection with a Change in Control under the circumstances described below. Capitalized terms not otherwise defined in this Agreement are defined in the Appendix to this Agreement.

BIOSOURCE INTERNATIONAL 820 Flynn Road Camarillo, CA 93012
Biosource International Inc • March 27th, 2001 • In vitro & in vivo diagnostic substances
AutoNDA by SimpleDocs
BioSource International, Inc. 540 Flynn Road Camarillo, California 93012
Biosource International Inc • March 27th, 2001 • In vitro & in vivo diagnostic substances
AMENDMENT NO. 1 TO WARRANT TO PURCHASE COMMON STOCK OF BIOSOURCE INTERNATIONAL, INC.
Biosource International Inc • June 8th, 2004 • In vitro & in vivo diagnostic substances
THIRD AMENDMENT TO RIGHTS AGREEMENT
Rights Agreement • July 26th, 2005 • Biosource International Inc • In vitro & in vivo diagnostic substances • Delaware

This Third Amendment to Rights Agreement (this “Amendment”), dated as of July 25, 2005, to the Rights Agreement, dated as of February 25, 1999, between BioSource International, Inc., a Delaware corporation (the “Company”), and U.S. Stock Transfer Corporation (“USSTC”), as Rights Agent, as amended on January 10, 2000 and as further amended on September 28, 2000 (as amended, the “Rights Agreement”).

BioSource International, Inc. 540 Flynn Road Camarillo, California 93012
Biosource International Inc • March 27th, 2001 • In vitro & in vivo diagnostic substances
INDEMNIFICATION AGREEMENT
Indemnification Agreement • May 26th, 2005 • Biosource International Inc • In vitro & in vivo diagnostic substances • Delaware

This Indemnification Agreement (this “Agreement”) is made as of this ___day of ___, 2005, by and between BioSource International, Inc., a Delaware corporation (the “Company”), and ___, an individual (“Indemnitee”).

Time is Money Join Law Insider Premium to draft better contracts faster.